Published in PLoS One on April 30, 2013
Estrongenic steroid hormones in lung cancer. Semin Oncol (2013) 0.89
International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators. Pharmacol Rev (2015) 0.87
Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways. PLoS One (2014) 0.85
Smoking out reproductive hormone actions in lung cancer. Mol Cancer Res (2014) 0.83
Endothelial estrogen receptor isoforms and cardiovascular disease. Mol Cell Endocrinol (2014) 0.80
Exogenous estradiol improves shell strength in laying hens at the end of the laying period. Acta Vet Scand (2014) 0.78
Adaptive increases in expression and vasodilator activity of estrogen receptor subtypes in a blood vessel-specific pattern during pregnancy. Am J Physiol Heart Circ Physiol (2015) 0.78
Editor's Highlight: Development of an In vitro Assay Measuring Uterine-Specific Estrogenic Responses for Use in Chemical Safety Assessment. Toxicol Sci (2016) 0.75
Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression. PLoS One (2017) 0.75
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol (2006) 5.20
Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res (2001) 4.23
Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol (1999) 3.74
A potent specific pure antiestrogen with clinical potential. Cancer Res (1991) 3.54
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem (2000) 3.34
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24
Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. Biochemistry (2007) 3.21
Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res (2000) 3.12
Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature (1977) 3.04
Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol (2003) 2.54
Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab (2001) 2.42
Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A (1994) 2.41
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun (2005) 2.37
Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem (2002) 2.31
A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci U S A (2006) 2.29
Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci U S A (2003) 2.22
ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol (2002) 2.20
Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst (1992) 2.19
Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell (2004) 2.07
Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J (1995) 2.03
Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol (2004) 2.00
Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci U S A (1967) 1.87
Plasma membrane estrogen receptors. Trends Endocrinol Metab (2009) 1.85
Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci U S A (2000) 1.83
Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol (2010) 1.77
Antagonists selective for estrogen receptor alpha. Endocrinology (2002) 1.70
Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity. J Med Chem (2004) 1.43
Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab (1995) 1.36
Insertion of membrane proteins into discoidal membranes using a cell-free protein expression approach. J Proteome Res (2008) 1.34
Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clin Chem Lab Med (2006) 1.28
Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation (2003) 1.25
Membrane protein expression: no cells required. Trends Biotechnol (2009) 1.25
The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol. Proc Natl Acad Sci U S A (2009) 1.23
Genomic and non-genomic effects of estrogens on endothelial cells. Steroids (2004) 1.20
ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways. PLoS One (2010) 1.14
Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol (1990) 1.11
S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem Biophys Res Commun (2004) 1.10
Nonnuclear actions of estrogen. Arterioscler Thromb Vasc Biol (2002) 1.08
The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol (1992) 1.06
A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells. Reprod Biol Endocrinol (2009) 1.00
SERMs: current status and future trends. Crit Rev Oncol Hematol (2002) 0.94
The role of ligand in estrogen receptor regulation of gene expression. Mol Cell Endocrinol (1991) 0.87
Kaempferol enhances endothelium-independent and dependent relaxation in the porcine coronary artery. Mol Cell Biochem (2006) 0.85
Soy isoflavones improve endothelial function in spontaneously hypertensive rats in an estrogen-independent manner: role of nitric-oxide synthase, superoxide, and cyclooxygenase metabolites. J Pharmacol Exp Ther (2005) 0.83
Nongenomic responses to 17beta-estradiol in male rat mesenteric arteries abolish intrinsic gender differences in vascular responses. Br J Pharmacol (2005) 0.80
Acetylcholine-mediated relaxation in rat thoracic aorta is enhanced following acute exposure to physiological concentrations of 17beta-estradiol. Mol Cell Biochem (2000) 0.79
Equilibrium hormone binding to human estrogen receptors in highly diluted cell extracts is non-cooperative and has a Kd of approximately 10 pM. J Steroid Biochem Mol Biol (1994) 0.76
EDHF: bringing the concepts together. Trends Pharmacol Sci (2002) 3.69
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol (2006) 2.97
Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol (2006) 2.69
SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res (2010) 2.20
Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res (2004) 2.13
Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation (2010) 1.85
Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res (2008) 1.78
Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) (2008) 1.77
Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol (2006) 1.74
Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes (2010) 1.71
EDHF: an update. Clin Sci (Lond) (2009) 1.67
Activation of A(2) adenosine receptors dilates cortical efferent arterioles in mouse. Kidney Int (2009) 1.60
Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol (2011) 1.51
Endothelium-dependent hyperpolarizations: past beliefs and present facts. Ann Med (2007) 1.47
Upregulation of heme oxygenase 1 by hemin impairs endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Hypertension (2011) 1.45
Adiponectin and cardiovascular health: an update. Br J Pharmacol (2012) 1.42
Cellular signaling and NO production. Pflugers Arch (2010) 1.38
Multiple ryanodine receptor subtypes and heterogeneous ryanodine receptor-gated Ca2+ stores in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2005) 1.38
APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab (2009) 1.36
Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF. Br J Pharmacol (2002) 1.34
Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circ Res (2010) 1.33
Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Proteomics (2009) 1.31
Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol (2002) 1.28
Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J Biol Chem (2010) 1.28
Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids. Br J Pharmacol (2005) 1.28
Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics (2007) 1.27
Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep (2010) 1.25
Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol (2008) 1.23
Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol (2005) 1.21
EDHF: new therapeutic targets? Pharmacol Res (2004) 1.21
Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells. Cancer Res (2008) 1.20
Endothelium-dependent contractions occur in the aorta of wild-type and COX2-/- knockout but not COX1-/- knockout mice. J Cardiovasc Pharmacol (2005) 1.19
Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res (2009) 1.17
Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am J Physiol Gastrointest Liver Physiol (2009) 1.15
SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model. FEBS Lett (2010) 1.15
Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J (2012) 1.15
Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflugers Arch (2010) 1.14
Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol (2011) 1.13
Nitric oxide: orchestrator of endothelium-dependent responses. Ann Med (2011) 1.13
A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR. Hypertension (2003) 1.12
Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions. Pharmacol Ther (2009) 1.09
Vasoconstrictor prostanoids. Pflugers Arch (2010) 1.09
Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol (2009) 1.07
Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. Circulation (2008) 1.07
N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. Free Radic Biol Med (2013) 1.07
Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice. Cell Metab (2011) 1.07
Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells. Br J Pharmacol (2011) 1.07
MMP-7 and cardiovascular disease: not so surprising! Basic Clin Pharmacol Toxicol (2012) 1.06
Epac1 mediates protein kinase A-independent mechanism of forskolin-activated intestinal chloride secretion. J Gen Physiol (2010) 1.06
Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arterioscler Thromb Vasc Biol (2011) 1.04
Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. J Pharmacol Exp Ther (2006) 1.03
Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal (2011) 1.01
Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes (2010) 1.01
Genomic changes in regenerated porcine coronary arterial endothelial cells. Arterioscler Thromb Vasc Biol (2007) 1.01
N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats. PLoS One (2013) 1.00
Acetylcholine and sodium nitroprusside cause long-term inhibition of EDCF-mediated contractions. Am J Physiol Heart Circ Physiol (2005) 0.99
Cell-cell interaction underlies formation of fluid in the male reproductive tract of the rat. J Gen Physiol (2005) 0.99
Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol (2013) 0.98
Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis. Circulation (2012) 0.98
PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Clin Sci (Lond) (2012) 0.98
The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res (2007) 0.98
Role of SK(Ca) and IK(Ca) in endothelium-dependent hyperpolarizations of the guinea-pig isolated carotid artery. Br J Pharmacol (2005) 0.98
The role of pharmacology in drug discovery. Nat Rev Drug Discov (2002) 0.97
Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol (2010) 0.96
Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. J Cardiovasc Pharmacol (2012) 0.96
APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice. Diabetes (2011) 0.96
Endothelium-dependent contractions to acetylcholine, ATP and the calcium ionophore A 23187 in aortas from spontaneously hypertensive and normotensive rats. Fundam Clin Pharmacol (2004) 0.95
Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology (2008) 0.95
Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? J Ethnopharmacol (2011) 0.95
Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol (2006) 0.94
Dexmedetomidine induces both relaxations and contractions, via different {alpha}2-adrenoceptor subtypes, in the isolated mesenteric artery and aorta of the rat. J Pharmacol Exp Ther (2010) 0.93
Blockade of beta 1- and desensitization of beta 2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis. Eur J Pharmacol (2004) 0.91
Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome. FASEB J (2013) 0.91
Endothelial mediators of the acetylcholine-induced relaxation of the rat femoral artery. Vascul Pharmacol (2006) 0.91
The thromboxane/endoperoxide receptor (TP): the common villain. J Cardiovasc Pharmacol (2010) 0.91
In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factors. Am J Physiol Heart Circ Physiol (2006) 0.91
Oxidative stress and pathological changes after coronary artery interventions. J Am Coll Cardiol (2013) 0.91
Non-genomic activation of adenylyl cyclase and protein kinase G by 17β-estradiol in vascular smooth muscle of the rat superior mesenteric artery. Pharmacol Res (2011) 0.90
Acute impairment of contractile responses by 17beta-estradiol is cAMP and protein kinase G dependent in vascular smooth muscle cells of the porcine coronary arteries. Br J Pharmacol (2005) 0.90
Vascular actions of adipokines molecular mechanisms and therapeutic implications. Adv Pharmacol (2010) 0.90
Specific potentiation of endothelium-dependent contractions in SHR by tetrahydrobiopterin. Hypertension (2003) 0.90
Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats. Respir Med (2009) 0.89
Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries. Am J Physiol Heart Circ Physiol (2011) 0.89
High binding capacity of cyclophilin B to chondrocyte heparan sulfate proteoglycans and its release from the cell surface by matrix metalloproteinases: possible role as a proinflammatory mediator in arthritis. Arthritis Rheum (2003) 0.89
Tissues cIMPly do not lie. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.88